Cargando…
Preparation and biodistribution of (188)Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles ((188)Re-folate-CDDP/HSA MNPs) in vivo
BACKGROUND: The purpose of this study was to develop intraperitoneal hyperthermic therapy based on magnetic fluid hyperthermia, nanoparticle-wrapped cisplatin chemotherapy, and magnetic particles of albumin. In addition, to combine the multiple-killing effects of hyperthermal targeting therapy, chem...
Autores principales: | Tang, Qiu-Sha, Chen, Dao-Zhen, Xue, Wen-Qun, Xiang, Jing-Ying, Gong, Yong-Chi, Zhang, Li, Guo, Cai-Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235028/ https://www.ncbi.nlm.nih.gov/pubmed/22163161 http://dx.doi.org/10.2147/IJN.S24322 |
Ejemplares similares
-
Rhenium-188 Production in Hospitals, by W-188/Re-188 Generator, for Easy Use in Radionuclide Therapy
por: Argyrou, Maria, et al.
Publicado: (2013) -
Intratumoral Injection of (188)Re labeled Cationic Polyethylenimine Conjugates: A Preliminary Report
por: Kim, Eun-Mi, et al.
Publicado: (2004) -
A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of (188)Re-liposome in patients with metastatic tumors
por: Wang, Shyh-Jen, et al.
Publicado: (2019) -
External beam radiotherapy synergizes (188)Re-liposome against human esophageal cancer xenograft and modulates (188)Re-liposome pharmacokinetics
por: Chang, Chih-Hsien, et al.
Publicado: (2015) -
(188)Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy
por: Boschi, Alessandra, et al.
Publicado: (2017)